Omnia Health is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Laboratory

Gene Therapy

OH-OHL Isssue
Omnia Health Magazine
Browse through the latest issue that covers COVID-19 developments, the impact of AI, telemedicine and blockchain in transforming healthcare delivery, and more.
Highlights
MPS 1.jpg
Combatting MPS 1 through innovation
Apr 15, 2020
A look at the rare and lethal condition Mucopolysaccharidosis Type 1 (MPS 1), and the initiatives being taken by the UAE to treat it.
DNA graphics
From the Lab to the Bedside: Embracing Personalised Medicine
Jan 15, 2020
According to the NHS England, personalised medicine (otherwise known as precision medicine) is a move away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to “one which uses new approaches to...